Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
69 2.8% |
 |
Gilead SciencesGILD |
55 1.9% |
 |
Catalyst PharmaceuticalsCPRX |
67 33% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Sep 2025 | 49 | |
| Aug 2025 | 52 | |
| Jul 2025 | 47 | |
| Jun 2025 | 65 |
How do employees feel about the future at Recursion Pharmaceuticals?
The Business Outlook at Recursion Pharmaceuticals is negative, according to employees. The rating, which is an average compiled from the top review sites in the US, is below average at 46 out of 100. Additionally, this rating has been trending downward in comparison to the previous month. Additionally, this rating has been trending downward in comparison to the previous month.
Analyzing Business Outlook, how is Recursion Pharmaceuticals performing compared to its industry peers?
Compared to its peers, Recursion Pharmaceuticals ranks in the 46th percentile when it comes to Business Outlook.
How has the business outlook at Recursion Pharmaceuticals changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Recursion Pharmaceuticals.
Why is it important to track the business outlook at Recursion Pharmaceuticals?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Recursion Pharmaceuticals.
